BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20461788)

  • 1. Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patients.
    Farragher TM; Plant D; Flynn E; Eyre S; Bunn D; Thomson W; Symmons D; Barton A
    Arthritis Care Res (Hoboken); 2010 May; 62(5):676-82. PubMed ID: 20461788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis.
    Farragher TM; Goodson NJ; Naseem H; Silman AJ; Thomson W; Symmons D; Barton A
    Arthritis Rheum; 2008 Feb; 58(2):359-69. PubMed ID: 18240242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Leukocyte Antigen Shared Epitope and Inflammation, Cardiovascular Disease, Cancer, and Mortality Among Postmenopausal Women in the Women's Health Initiative Rheumatoid Arthritis Study.
    Birru Talabi M; Mackey RH; Kuller LH; Dorman JS; Deane KD; Robinson WH; Walitt BT; Chang Y; Holers VM; Liu S; Moreland LW
    Am J Epidemiol; 2017 Jul; 186(2):245-254. PubMed ID: 28459968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR).
    Mirjafari H; Welsh P; Verstappen SM; Wilson P; Marshall T; Edlin H; Bunn D; Chipping J; Lunt M; Symmons DP; Sattar N; Bruce IN
    Ann Rheum Dis; 2014 Apr; 73(4):684-90. PubMed ID: 23511225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PTPN22*C1858T functional polymorphism is associated with susceptibility to inflammatory polyarthritis but neither this nor other variants spanning the gene is associated with disease outcome.
    Naseem H; Thomson W; Silman A; Worthington J; Symmons D; Barton A
    Ann Rheum Dis; 2008 Feb; 67(2):251-5. PubMed ID: 17666450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register.
    Plant D; Thomson W; Lunt M; Flynn E; Martin P; Eyre S; Farragher T; Bunn D; Worthington J; Symmons D; Barton A
    Rheumatology (Oxford); 2011 Jan; 50(1):78-84. PubMed ID: 20219786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
    Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
    Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study.
    Orozco G; Eyre S; Hinks A; Ke X; ; Wilson AG; Bax DE; Morgan AW; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Thomson W; Barton A; Worthington J
    Ann Rheum Dis; 2010 May; 69(5):813-6. PubMed ID: 19435719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register.
    Farragher TM; Lunt M; Bunn DK; Silman AJ; Symmons DP
    Ann Rheum Dis; 2007 Apr; 66(4):486-92. PubMed ID: 17090565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
    Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
    Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
    Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between CCL21 gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.
    Li G; Zhao J; Li B; Ma J; Zhao Q; Wang X; Lv Z; Li K; Du Z; Ma X; Liu J
    Rheumatol Int; 2017 Oct; 37(10):1673-1681. PubMed ID: 28799100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis.
    Naz SM; Farragher TM; Bunn DK; Symmons DP; Bruce IN
    Arthritis Rheum; 2008 Apr; 58(4):985-9. PubMed ID: 18383358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients.
    García-Bermúdez M; López-Mejías R; Genre F; Castañeda S; González-Juanatey C; Llorca J; Corrales A; Miranda-Filloy JA; Rueda-Gotor J; Gómez-Vaquero C; Rodríguez-Rodríguez L; Fernández-Gutiérrez B; Pascual-Salcedo D; Balsa A; López-Longo FJ; Carreira P; Blanco R; González-Álvaro I; Martín J; González-Gay MA
    PLoS One; 2013; 8(10):e77695. PubMed ID: 24204921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
    Potter C; Hyrich KL; Tracey A; Lunt M; Plant D; Symmons DP; Thomson W; Worthington J; Emery P; Morgan AW; Wilson AG; Isaacs J; Barton A;
    Ann Rheum Dis; 2009 Jan; 68(1):69-74. PubMed ID: 18375541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients.
    Goodson NJ; Brookhart AM; Symmons DP; Silman AJ; Solomon DH
    Ann Rheum Dis; 2009 Mar; 68(3):367-72. PubMed ID: 18408253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis.
    García-Bermúdez M; López-Mejías R; González-Juanatey C; Castañeda S; Miranda-Filloy JA; Blanco R; Fernández-Gutiérrez B; Balsa A; González-Álvaro I; Gómez-Vaquero C; Llorca J; Martín J; González-Gay MA
    Scand J Rheumatol; 2012 Oct; 41(5):350-3. PubMed ID: 22657383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.
    Goodson NJ; Wiles NJ; Lunt M; Barrett EM; Silman AJ; Symmons DP
    Arthritis Rheum; 2002 Aug; 46(8):2010-9. PubMed ID: 12209502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.